RTOG 0518: randomized phase III trial to evaluate zoledronic acid for prevention of osteoporosis and associated fractures in prostate cancer patients

RTOG 0518: randomized phase III trial to evaluate zoledronic acid for prevention of osteoporosis and associated fractures in prostate cancer patients

Prostate Cancer and Prostatic Diseases advance online publication, October 1 2013.
doi:10.1038/pcan.2013.35

Authors: L A Kachnic, S L Pugh, P Tai, M Smith, E Gore, A B Shah, A-G Martin, H E Kim, A Nabid
& C A F Lawton

Source: Prostate Cancer and Prostatic Diseases - October 1, 2013 Category: Urology & Nephrology Authors: L A KachnicS L PughP TaiM SmithE GoreA B ShahA-G MartinH E KimA NabidC A F Lawton Tags: radiation therapy androgen deprivation therapy osteoporosis bone fractures Source Type: research